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Abstract
The aberrant expression of the transmembrane protein EpCAM is associated with tumor progression, affecting different
cellular processes such as cell–cell adhesion, migration, proliferation, differentiation, signaling, and invasion. However, the in
vivo function of EpCAM still remains elusive due to the lack of genetic loss-of-function studies. Here, we describe epcam
(tacstd) null mutants in zebrafish. Maternal-zygotic mutants display compromised basal protrusive activity and epithelial
morphogenesis in cells of the enveloping layer (EVL) during epiboly. In partial redundancy with E-cadherin (Ecad), EpCAM
made by EVL cells is further required for cell–cell adhesion within the EVL and, possibly, for proper attachment of underlying
deep cells to the inner surface of the EVL, thereby also affecting deep cell epiboly movements. During later development,
EpCAM per se becomes indispensable for epithelial integrity within the periderm of the skin, secondarily leading to
disrupted morphology of the underlying basal epidermis and moderate hyper-proliferation of skin cells. On the molecular
level, EVL cells of epcam mutant embryos display reduced levels of membranous Ecad, accompanied by an enrichment of
tight junction proteins and a basal extension of apical junction complexes (AJCs). Our data suggest that EpCAM acts as a
partner of E-cadherin to control adhesiveness and integrity as well as plasticity and morphogenesis within simple epithelia.
In addition, EpCAM is required for the interaction of the epithelia with underlying cell layers.
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Introduction
Like in mammalian gestation embryos, the epidermis of teleost
larvae is bi-layered, consisting of an outer enveloping cell layer
(EVL), which morphologically and functionally resembles the
periderm of mammalian embryos [1,2], and a basal layer of
keratinocytes. The function of the mouse periderm is poorly
understood, however, recent genetic evidence points to pivotal
roles during skin formation and other developmental processes [3].
Furthermore, the zebrafish EVL might serve as a model for other,
medically more relevant simple epithelia, such as the epithelial
tubules of the developing zebrafish kidney, which during nephron
morphogenesis display several crucial cellular features [4] similar
to those of the EVL described here.
Zebrafish EVL cells segregate from deep cells during blastula
stages and cover the embryo during further development [5], while
it remains unclear whether during metamorphosis, when the
zebrafish epidermis becomes stratified, they are replaced by cells
derived from basal keratinocytes [6]. During gastrulation, EVL cells
undergo epiboly movements to progressively spread over the yolk,
tightly coordinated with the simultaneous vegetal-wards displace-
ments of deep cells and the yolk syncytial layer (YSL) [7–9]. Epiboly
movements start approximately 4 hours after fertilization (hpf),
when only 30% of the yolk cell is covered by the blastoderm (30%
epiboly), and is completed at 10 hpf, when the yolk is entirely
surrounded by deep and EVL cells (100% epiboly). The molecular
mechanisms underlying EVL epiboly have just started to be
elucidated [10], whereas the Ca
2+-dependent cell adhesion
molecule and adherence junction (AJ) component E-cadherin
(Ecad; Cdh1) has been shown to be specifically required for epiboly
of deep cells [11,12]. The major force of deep cell epiboly is their
polarized intercalative displacement from inner to outer layers.
According to one report, Ecad drives these directed intercalations
by forming an adhesion gradient within the deep layers themselves
[11], whereas according to another report, it is required for proper
attachment of deep cells to the overlying EVL [12].
In addition, the EVL serves as a primary ‘‘skin’’, constituting a
barrier between the embryo proper and the fresh water
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sealed to each other via apical junctional complexes (AJCs), which
consist of tight junction (TJ) and, possibly, AJ sections [13]. TJ
proteins like Tjp/Zo1 and Tjp/Zo3 already accumulate at the
lateral/apical sides of EVL membranes during early blastula
stages, while loss of Tjp/Zo3 function results in increased surface
permeability and compromised osmoregulation [14]. In addition,
EVL cells form desmosome-like junctions between each other and
with underlying cells [12,13].
EpCAM was first described in 1979 as a 40 KDa cell surface
cancer-associated antigen [15,16]. In addition, it was isolated in
several other contexts, which resulted in a plethora of synonyms such
as Tacstd1 or Trop1, recently unified under the name Epithelial cell
adhesion molecule (EpCAM) or CD326 (reviewed in [17,18]).
EpCAM is a type I single span transmembrane glycoprotein, with
extracellular epidermal growth factor-like (EGF-like) and thyroglob-
ulin (TY) motifs [17,19,20], and an intracellular domain containing
an internalization motif and several a-actinin binding sites [19]. In
mammals, EpCAM is present on the baso-lateral surface of most
developing epithelia [21–26]. Expression is usually down-regulated as
epithelial cells terminally differentiate. For example, progenitor cells
of human skin epithelium express EpCAM, whereas differentiated
keratinocytes do not [22]. However, EpCAM levels often rise again
during regeneration or neoplastic transformations [18,23,24,27–29].
Strikingly, EpCAM is only found in epithelial-derived cancers, i.e.,
carcinomas, but not in others, such as sarcomas, melanomas, or
lymphomas [30].
Despite exhaustive in vitro studies, the exact roles of EpCAM
during tumor progression and the molecular and cellular
mechanisms of its functions are not fully understood, with several
controversial findings, implicating EpCAM with adhesion, migra-
tion, metastasis, proliferation, differentiation, signaling and
metabolism (reviewed in [18,31]). Whereas according to some
data, EpCAM acts as a homophilic cell-cell adhesion molecule
with positive effects on cell adhesiveness and negative effects on
cell motility and metastasis [26,32–34], other data are in line with
anti-adhesive and migration-promoting functions of EpCAM.
Thus, in the presence of classical cadherins, EpCAM can reduce
cell-cell adhesion, possibly by interfering with the interaction
between cadherins and the cytoskeleton [20,35]. In addition,
EpCAM physically interacts with the metastasis-promoting cell
surface receptor CD44v4-V7 [36] and the tight junction
component Claudin7 [37], possibly blocking Claudin function
during invasion and metastasis of several carcinomas [38,39].
Furthermore, EpCAM enhances proliferation rates of carcinoma
cells [34,40], presumably mediated via direct nuclear signaling of
its proteolytically cleaved intracellular domain EpICD [41], and
via c-Myc and the cell cycle regulators cyclin A and E [42–44].
Most of these functional data were obtained in cell or tissue
culture systems and via EpCAM overexpression. In contrast, in
vivo and loss of function studies are scarce. No EpCAM mouse
mutants have been reported so far. In zebrafish, EpCAM (Tacstd)
mutants were generated via random retroviral insertions, charac-
terized by delayed otolith formation in the developing inner ears
[45]. In this study we generate maternal-zygotic zebrafish EpCAM
mutants and chimeric embryos, revealing essential roles of
EpCAM in the EVL for proper epithelial morphogenesis integrity
during epiboly and skin development. Some of these roles are
fulfilled in partial or complete redundancy with E-cadherin,
whereas for others, EpCAM is absolutely indispensable. The
molecular mechanisms underlying these in vivo functions are not
completely clear. However, mutant cells display basal extensions of
TJs and increased membrane levels of TJ components, coupled
with reduced Ecad membrane localization and reduced protrusive
basal activity. After skin formation, mutants also display hyper-
proliferation of EVL and the underlying epidermal cells, which,
however, seems to be a secondary consequence of the epithelial
defects. We conclude that EpCAM acts as cell-cell adhesion
molecule and a partner of E-cadherin, promoting both epithelial
integrity and epithelial morphogenesis.
Results
epcam zebrafish mutants were identified in screen for
abnormal skin development
To identify genes with essential functions during zebrafish skin
development, we performed an antibody-based screen on a
previously described bank of retroviral insertional mutants [45],
staining larvae at 120 hours post fertilization (hpf) for the basal
keratinocyte-specific transcription factor DNp63, which is required
for epidermal development in both fish and mammals [46–51].
The bank contained two mutant alleles of epcam (ZFIN: tacstd;
GenBank accession number NM212175), hi2151 and hi2836,
which were described to have delayed otolith development
(Figure 1A and 1B) [45]. In the case of hi2836, the retroviral
cassette is inserted upstream from exon 1 of the EpCAM gene,
whereas the insertion in hi2151 is within exon 2, causing a frame
shift and premature termination of the protein that removes all
annotated functional domains (Figure 1D and 1E). In our assay,
both alleles displayed aggregates of basal keratinocytes of
undistinguishable strengths (Figure 1A and 1B; and data not
shown). Similar aggregates, as well as the characteristic delay in
otolith development, were observed in embryos injected with an
antisense morpholino oligonucleotide (MO) targeting the transla-
tional start site of epcam mRNA (Figure 1C).
epcam mutants kept under standard conditions (28uC) usually
died between day 5 and 7 of development, whereas they were sub-
Author Summary
EpCAM is a well-established marker for carcinomas of
epithelial origin and a potential target for immunotherapy.
In vitro analyses have implicated EpCAM in a plethora of
different cellular processes, such as adhesion, motility,
proliferation, differentiation, and signaling. Strikingly,
depending on the context, EpCAM displayed rather
opposite effects, either promoting or attenuating cell–cell
adhesion versus cell migration and tissue invasion, a
phenomenon described as the ‘‘double-face’’ of EpCAM.
However, the in vivo relevance of its different effects
remained largely unclear. Here, we present the first genetic
analysis of EpCAM function in vivo, based on loss-of-
function mutants in the zebrafish. As it is in mammals,
zebrafish EpCAM is expressed in simple epithelia. Mutant
embryos display defects both in epithelial morphogenesis
and in epithelial integrity. Reduced epithelial morphogen-
esis is accompanied, and possibly caused, by an extension
of apical junctional complexes and compromised basal
protrusive activity. Furthermore, mutant epithelia display
alterations in the relative abundance of adherence
junction versus tight junction components. In addition,
EpCAM tightly cooperates with E-cadherin and has a
previously unrecognized trans effect on the morphogen-
esis and integrity of underlying cell layers. Cell differenti-
ation and proliferation in EpCAM mutants are not, or only
secondarily, affected. During later development and
adulthood, EpCAM is largely dispensable, reinforcing its
suitability as a target for anti-carcinoma immunotherapy
with minimal side effects.
Zebrafish EpCAM Mutant
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temperature (25uC). However, keratinocyte aggregates of survivors
remained visible throughout the first three weeks of development,
and fish grew more slowly (Figure S1B, S1C). Adult homozygous
mutants were fertile and appeared morphologically normal, even
in histological studies (data not shown).
Maternal epcam transcripts are ubiquitously distributed,
whereas zygotic expression is restricted to epithelial
structures, including the skin
epcam was previously shown to be expressed in migrating
neuromast primordia, otic vesicles and olfactory placodes [52–54].
Here, we have extended these analyses with special focus on the
skin. Maternally provided epcam mRNA was uniformly distributed
in all cells of cleavage and early blastula stage embryos (Figure 2A).
After the onset of epiboly, the first of the morphogenetic
movements of gastrulation, during which the yolk becomes
progressively overgrown by the blastoderm [7], epcam mRNA
was restricted to the enveloping layer (EVL), whereas deep cells
had become epcam-negative (Figure 2B–2D). In offspring of
homozygous hi2151 or hi2836 mothers and heterozygous fathers,
all embryos lacked epcam transcripts at cleavage stages (compare
Figure 2F with Figure 2E), whereas at early gastrulation, only 50%
(most likely M2/2,Z2/2; see below) remained negative, while
the other half (M2/2,Z+/2) had gained normal EVL expression
(Figure 2G). This indicates that zygotic epcam expression starts at
blastula stages. In addition, it suggests that the hi2836 and hi2151
mutations cause a transcriptional blockade or mRNA instability,
respectively, and that both alleles are null mutations.
At 24 and 48 hours post fertilization (hpf), in addition to the
previously described epithelial structures (see above; Figure 2H
and 2K), we noticed persistent epcam expression in the EVL and
expression in the basal epidermis (Figure 2I and 2J), a derivative of
the ventral ectoderm which during gastrula and early segmenta-
tion stages had been epcam-negative (Figure 2C). This expression
persisted throughout the investigated larval stages (until 120 hpf).
Also, according to RT-PCR analyses, epcam RNA was present in
the skin of adult zebrafish (data not shown). To investigate the
subcellular distribution of EpCAM protein, we tried immuno-
stainings with different antibodies against human or mouse
EpCAM (see Materials and Methods), however, none of them
gave specific signals (data not shown). Therefore, we injected early
zebrafish embryos with mRNA encoding full-length zebrafish
EpCAM fused to Green fluorescent protein (GFP). The fusion
protein was detected at the cell membrane of both EVL and deep
cells (Figure 2L and 2M).
Figure 1. epcam mutants and morphants display smaller otoliths and keratinocyte aggregation. Panels (A–C) show wild-type siblings
(WT, A), zygotic (M+/2,Z2/2) epcam mutants (epcam 2/2) and epcam morphants (epcam MO); upper panels show larvae at 120 hpf after anti-p63
immunostainings of basal keratinocytes, lower right panels show magnification of tail tip regions, and lower left panels show lateral views on otic
vesicles of live embryos at 48 hpf. Red arrows point to otoliths, which are smaller in mutants, but which recover later (see Figure S1). (D,E) Schematic
illustration of the two epcam alleles generated by retroviral insertional mutagenesis [45]. In hi2836 the retroviral cassette is inserted upstream of
exon1 (D), disrupting epcam transcription. In hi2151 the insertion is 42 base pairs downstream of the translational initiation site, introducing
termination codons in all reading frames and leading to a premature termination of the protein that removes all described functional domains of
EpCAM (EGF, epidermal growth factor-like domain; TY, thyroglobulin domain; TM, transmembrane domain) (D,E).
doi:10.1371/journal.pgen.1000563.g001
Zebrafish EpCAM Mutant
PLoS Genetics | www.plosgenetics.org 3 July 2009 | Volume 5 | Issue 7 | e1000563Figure 2. Zebrafish epcam is expressed in multiple epithelia, including the skin. (A–J) In situ hybridizations with anti-sense epcam probe.
(A) Maternally provided epcam RNA is uniformly distributed in all blastomeres of 4-cell stage embryo (1 hpf). (B–D) At the 50% epiboly stage (early
gastrula; 5.5 hpf), epcam expression is restricted to the outer EVL layer. (C,D) show 8 mm thick paraffin sections; in (D) epcam-negative deep cells (dc)
and yolk syncitial layer (ysl) are indicated. (E–G) Mutant epcam mRNA is unstable, and zygotic epcam transcription is initiated before gastrulation. (E)
Wild-type (WT) embryos at 8–16 cell stage; (F,G) embryos from cross of homozygous mutant female (M2/2) and heterozygous male, 50% of which
are zygotic heterozygotes (Z+/2), and 50% zygotic homozygous mutants (Z2/2). At the 8–16 cell stage (F), all embryos lack (maternally supplied)
epcam transcripts. At the 50% epiboly stage (G), Z2/2 embryos still lack epcam mRNA, whereas zygotically derived transcripts are detectable in Z+/2
embryos, indicating that zygotic epcam transcription starts shortly after midblastula transition [88]. (H–K) At 24 hpf (H–J) and 48 hpf (K), epcam is
expressed in the olfactory placodes (olf), otic vesicles (ot), head and lateral line neuromasts (nm), pronephric ducts (pd) and the skin; (I,J) transverse
sections through trunk of 24 hpf embryo labeled for epcam RNA (in blue) and p63 protein (in brown). epcam is expressed both in the (p63-negative)
outer EVL (arrow in J), and in the underlying layer of p63-positive basal keratinocytes (arrowhead in J). (L, M) Epifluorescent images of live embryo at
9 hpf. Upon injection of mRNA encoding EpCAM-GFP, the fusion protein localizes to the cell membrane of both EVL cells (L) and the underlying deep
cells (M). Note the size differences between the two cell types.
doi:10.1371/journal.pgen.1000563.g002
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Early zebrafish development is regulated by a combination of
maternal factors (deposited in the egg during oogenesis) and
zygotic factors generated by the embryo itself. Crossing homozy-
gous or heterozygous epcam mutant females with heterozygous
males, we could generate mutants of three different genotypes:
M+/2,Z2/2, which still have the maternally supplied epcam gene
products, but lack the embryonic contribution (zygotic effect),
M2/2,Z+/2, which lack the maternal, but contain embryonic
gene products (maternal effect), and M2/2,Z2/2, which lack
both the maternal and the embryonic supply (maternal-zygotic
effect; MZ2/2). By all means M2/2,Z+/2 mutants had wild-
type appearance, indicating that zygotic epcam gene products are
sufficient for normal development. Nevertheless, defects of MZ2/2
embryos were more severe and developed earlier than in zygotic
mutants, indicating that maternally supplied gene products can
partly take over the role of zygotic epcam: whereas skin aggregates in
zygotic mutants only developed during the second day of
development (data not shown), in MZ2/2 mutants, they were
already apparent at mid-segmentation (16 hpf; Figure 3A and 3B),
while later, skin aggregates were larger (Figure S1A), and high
numbers of shed skin cells were found floating in the chorion
(starting at approximately 16 hpf; see Figure 3G for 36 hpf). At
16 hpf, aggregates often occurred in the tailbud region, where the
tail grows out. Here, the skin is most likely exposed to highest
mechanical pressure and/or undergoes most dramatic epithelial
morphogenesis (Figure 3B). To investigate cell aggregates in greater
detail, we took advantage of a transgenic zebrafish line in which
EVL cells are labeled by GFP [55]. Our analysis showed that the
early skin aggregates in MZ2/2 embryos primarily consisted of
EVLcells,whichhadacquiredaroundishshapeandhadpiledupon
each other. In contrast, p63-positive basal cells underneath the foci
seemed unaltered (Figure 3C–3E), and only formed aggregates
much later (see Figure S1A for 48 hpf). At these later stages, epcam is
expressed both in EVL and basal cells (see above; Figure 2J). To
distinguish whether the late aggregation of basal cells is caused by a
lossofEpCAMinbasalcellsthemselves,orbyitslossintheoverlying
EVL cells, we generated chimeric embryos, transplanting basal
MZ2/2 cells into wild-type hosts and vice versa [56]. Strikingly,
even largest clones of mutant basal cells were organized normally
when present in a wild-type environment (compare Figure 3I with
Figure 3H), whereas clones of wild-type basal cells in mutant hosts
formed aggregates indistinguishable from those in non-chimeric
mutants (Figure 3J). In sum, this indicates that EpCAM from EVL
cells is required for proper epithelial organization both within the
enveloping layer per se and in the underlying layer of basal
keratinocytes.
epcam mutants exhibit secondary increase in EVL and
epidermal proliferation
Elevated EpCAM levels in transformed tissues are thought to
promote cell proliferation, contributing to carcinoma progression
[34,40]. To determine proliferation rates in zebrafish epcam
mutants, we carried out Bromodeoxyuridine (BrdU) incorporation
studies in combination with EVL or epidermal-specific markers
[56]. During somitogenesis (16 hpf), when EVL aggregation and
cell shedding is already apparent, we could not detect any
difference in the number of BrdU labeled cells between mutants
and their WT siblings (Figure 4A and 4B). At 24 hpf, proliferation
rates in both the EVL and the basal layer of epcam mutants were
slightly elevated, while at 48 hpf, this difference only persisted in
the EVL, but not in the basal layer (Figure 4A and 4B). Strikingly,
aggregates of mutant EVL or basal cells displayed BrdU
incorporation rates as in non-affected regions of the skin
(Figure 4C; and data not shown). Together, this suggests that cell
aggregates in epcam mutants are not due to hyper-proliferation and
that, in turn, hyper-proliferation might be a secondary conse-
quence of compromised epithelial integrity.
EpCAM mutants display higher infection susceptibility
and enhanced skin inflammation
At 24 hpf and later, we also observed increased numbers of
leukocytes in the skin of MZepcam mutants (Video S1, Video S2;
and data not shown), similar to the recently described defects in
zebrafish mutants lacking the Hepatocyte growth factor activator
inhibitor Hai1 [56,57]. However, genetic ablation of the myeloid
lineage in MZepcam mutants with pu.1 antisense MOs [58] did not
ameliorate the skin defects, ruling out that they are secondary
consequences of enhanced skin inflammation (data not shown). In
hai1 mutants, skin invasion by innate immune cells might be
triggered by the apoptosis of skin cells [56]. However, according to
TUNEL stainings, even the skin aggregates of EpCAM mutants
only displayed moderately increased numbers of apoptotic cells
after 48 hpf (Figure 4D; data not shown), making such a
mechanism rather unlikely. To test whether leukocytes are
activated as a result of compromised skin barrier and enhanced
infection, we compared wild-type and mutant embryos kept under
semi-sterile conditions or after incubation in water contaminated
with bacteria. Under semi-sterile conditions, wild-type and mutant
embryos displayed identical patterns of leukocyte distribution,
revealed via leukocyte-specific-plastin (lcp1) [59,60] in situ hybridiza-
tion at 48 hpf (Figure S2A, S2B). However, after bacterial
challenge for 2 hours, the skin of epcam mutants contained much
more inate immune cells (Figure S2D) than in challenged wild-
type controls (Figure S2C) or un-challenged mutant siblings
(Figure S2B). In sum, these data suggest that loss of EpCAM
primarily affects epithelial properties of the enveloping cell layer,
whereas dysmorphology of the basal layer, hyper-proliferation,
apoptosis, infection and inflammation are later or secondary
consequences.
Loss of epcam causes compromised protrusive activity
and morphogenesis in EVL cells during epiboly
The EVL-specific defects of MZepcam mutants during segmen-
tations stages prompted us to carry out more thorough analyses of
this cell lineage during earlier development. During epiboly, cells
throughout the EVL flatten out and increase their apical and basal
surfaces [8,9], while marginal EVL cells constrict, involving actin
and myosin 2 that is localized in the yolk cytoplasm along the
margin of the EVL [10]. In MZepcam mutant embryos, this
constriction occurred at positions slightly closer to the animal pole
than in wild-type embryos, resulting in an extrusion of the vegetal-
most part of the yolk at mid gastrula stages (Figure 5A and 5B)
and, sometimes, in embryonic death. This suggests that loss of
EpCAM might specifically affect the vegetal-wards spreading of
the EVL, but not the actin-myosin-dependent constriction of
marginal EVL cells. Compromised EVL epiboly as a result of
reduced constrictions at the EVL margin has recently been
described for embryos after knock-down of msn1, the zebrafish
ortholog of the Drosophila Ste20-like kinase Misshapen that is
required for actin/myosin 2 recruitment, or after treatment with
the specific myosin 2 inhibitor blebbistatin [10]. In contrast,
phalloidin stainings of the actin cytoskeleton revealed normal
constrictions of marginal EVL cells in MZepcam mutants (Figure
S3). However, MZepcam mutants did display a significant
reduction in yolk coverage by the EVL at late gastrula stages
(7764.9% (n=9) versus 8964.7% (n=10) in wild-type embryos of
Zebrafish EpCAM Mutant
PLoS Genetics | www.plosgenetics.org 5 July 2009 | Volume 5 | Issue 7 | e1000563Figure 3. First cell aggregates of maternal/zygotic epcam mutants are formed during mid segmentation stages, starting in the EVL,
whereas basal cell aggregates form secondarily. (A,B) Maternal/zygotic (MZ) epcam mutant at 16 hpf (12-somite stage) (B) with skin aggregate
on tailbud (red arrow). (C–E) Confocal images of skin aggregate at 16 hpf; (C) merged stack of sagittal sections; (D) merged stack and (E) single layer
of transverse sections; EVL cells labeled in green (anti-GFP immunostaining of tg(cytokeratin8:GFP) product), nuclei of basal keratinocytes in red (anti-
p63 immunostaining). The EVL is ruptured (C), EVL cells have rounded up and have piled up on each other (D,E). In contrast, the underlying basal
layer is normally organized, with regularly spaced p63-positive nuclei (D,E). (F,G) Live images of un-hatched embryos at 36 hpf. Sloughed skin cells are
present within the chorion of mutant embryo (G). (H–J) Aggregates of basal keratinocytes are formed as a consequence of the loss of EpCAM function
in the EVL; stacks of confocal images; transplanted basal cells are stained for GFP in green, nuclei of basal cells for p63 in red. (H) Non-chimeric wild-
type control. (I) Chimeric embryo with cluster of MZepcam mutant basal cells (in green) in wild-type environment/underneath wild-type EVL, with
normal spatial organization of mutant basal cells. (J) Chimeric embryo with cluster of wild-type basal cells (in green) underneath MZepcam mutant
EVL, with aggregations of wild-type basal cells.
doi:10.1371/journal.pgen.1000563.g003
Zebrafish EpCAM Mutant
PLoS Genetics | www.plosgenetics.org 6 July 2009 | Volume 5 | Issue 7 | e1000563Figure 4. MZepcam mutants display secondary increase in proliferation and apoptosis of EVL cells and basal keratinocytes. (A)
Confocal images of maternal/zygotic epcam (MZ2/2) mutant and wild type (WT) embryos at indicated stages. EVL cells and their nuclei are in green
(anti-GFP immunostaining of tg(cytokeratin8:GFP) product; row 1), nuclei of basal keratinocytes in red (anti-p63 immunostaining; row 2), and BrdU-
positive nuclei in blue (row 3). Row 4 shows merged images; row 5 magnified views of regions boxed in row 4 in red. They show examples of BrdU-
positive EVL (in light blue; green+blue) and basal cell nuclei (in purple; red+blue). (B) Percentages of BrdU-positive EVL (in blue) and basal layer (in
red) nuclei in WT and MZ2/2 embryos at the indicated stages of development. (C) Confocal image of aggregate of p63-positive basal cells (in red) at
48 hpf; the aggregate is devoid of BrdU incorporation (in green), whereas BrdU-positive nuclei are present outside the aggregate, indicating that the
assay worked. (D) Analysis of apoptosis levels within epidermal aggregates of MZ2/2 embryos. At 48 hpf, aggregates contain very few or no TUNEL-
positive cells (green), while more apoptotic cells are found in aggregates at 96 hpf.
doi:10.1371/journal.pgen.1000563.g004
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reduction in the average surface of individual EVL cells (Figure 5I,
5J, and 5K). Epiboly of deep cells was similarly delayed in
MZepcam mutants (7264.8% (n=9) versus 8363.1% (n=10) in
wild type embryos; Figure 5C, 5D, and 5G), while the distance
between the marginal borders of the EVL and the deep cell layer
was as in wild-type embryos (Figure 5E, 5F, and 5H).
Furthermore, and most strikingly, whereas the lateral sides of
marginal and, to a lower extent, equatorial wild-type EVL cells
appeared ruffled, indicating the presence of (basal; see below)
cellular protrusions, MZepcam mutant cells lacked these ruffles
(Figures 5I and 5J and Figure 6A–6G). Ruffles could be at least
partly restored by injection of synthetic epcam mRNA into mutant
embryos (Figure 6G–6I). However, no rescue was obtained upon
epcam re-introduction into single EVL cells (Figure 6J; n=0/13),
suggesting that EpCAM does not act in a strictly cell-autonomous
manner, but is most likely also required in the neighboring cells to
allow proper ruffle formation. Together, these data indicate that
EpCAM is required for processes of epithelial morphogenesis
driving the cell shape changes and spreading of the EVL during
zebrafish epiboly.
epcam mutant EVL cells display compromised basal
protrusion formation, basally extended apical junctional
complexes, and reduced E-cadherin levels in the
basolateral membrane
To further investigate the cellular basis of the epithelial defects
of MZepcam mutants, we performed immunohistochemistry and
transmission electron microscopy (TEM). Consistent with the
ruffles visualized via phalloidin stainings (see above; Figure 5I),
TEM revealed protrusions at the basal side of wild-type EVL cells
Figure 5. EpCAM is required for EVL and deep cell layer epiboly. (A,B) Live animals at the 90% epiboly stage, dorsal to the right; (C–F,I,J)
phalloidin stainings of the actin cytoskeleton at 80% epiboly. (A,B) One of the morphogenetic processes during epiboly is the constriction of marginal
EVL cells [10]. In mutants, this constriction does occur, however, at aberrant, slightly more animal positions, leading to a protrusion of the yolk plaque
(B). (C,D) Overview over entire embryos; red bars indicate the animal (A) - vegetal (V) axis, and the margins of the deep cell layers (dc) and the
enveloping layer (evl). The mutant (D) displays slightly retarded epiboly of the EVL and the deep cells (see larger distances between the evl margin
and the vegetal pole (evl-V) and between the dc margin and the vegetal pole (d-V) compared to wild-type control in C). (G) Graphic demonstration of
average progression of evl and dc epiboly in MZ2/2 mutants and wild-type controls (WT). Percentage values were calculated from images like in
(C,D) as (distance A-evl)/(distance A-V) or (distance A-dc)/distance (A-V). Standard deviations are indicated. For exact numbers see Text S1. (E,F)
Magnified views on the evl and dc margins; dc margins are indicated by dashed red lines. (H) Graphic demonstration of average evl-dc distances in
MZ2/2 mutants and WT controls, as shown in (E,F). n=5; standard errors are indicated. (I,J) Magnified views on EVL in regions slightly animal of the
deep cell border (merged Z-stacks of confocal images), revealing ruffle-like protrusions in the wild type (I) that are missing in the mutant (J). The
presence of intracellular, vesicular-like phalloidin staining varied from embryo to embryo, and even from cell to cell, but seemed unrelated to the
epcam genotype. (K) Graphic demonstration of average horizontal sizes of EVL cells of WT and MZ2/2 embryos at 80% epiboly, as shown in (E,F).
n=30; standard errors are indicated.
doi:10.1371/journal.pgen.1000563.g005
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PLoS Genetics | www.plosgenetics.org 8 July 2009 | Volume 5 | Issue 7 | e1000563Figure 6. Ruffle formation in marginal EVL cells is partly restored upon uniform re-introduction of epam via RNA injection, whereas
epcam overexpression in single EVL cells is insufficient. (A–F) Phalloidin stainings of wild type (WT) and maternal zygotic EpCAM mutant
(MZ2/2) EVL cells at two different positions, equatorial (A–C) and marginal (D–F); merged Z-stacks of confocal images. In WT embryos, marginal EVL
cells are much more protrusive than equatorial EVL cells, while in MZ2/2 embryos, EVL cells show practically no protrusive activity at both locations.
First four columns of panel (G) show quantification of protrusive activity. (H,I) Phalloidin stainings of marginal EVL cells from un-injected maternal/
zygotic EpCAM mutant (MZ2/2) (H) and MZ2/2 mutant injected with zebrafish epcam mRNA (I), 80% epiboly stage. There was a partial restoration
of the protrusive activity of the EVL cells (red arrow in H), as quantified in (G), columns 5 and 6. Injection of higher amounts of epcam mRNA caused
progressive death of injected embryos during pre- or early gastrula stages (data not shown), most likely due to ectopic effects of applied EpCAM in
the deep cells, which precluded analyses of the EVL phenotype. (J) Injection of plasmid DNA encoding EpCAM-GFP fusion protein under the control
of CMV promoter in MZ2/2 embryos led to high recombinant protein levels in single cells. In most cases, this also caused death of expressing cells
(data not shown). The few surviving EVL cells failed to restore ruffles (n=0/13), suggesting that ruffle formation also requires EpCAM function in
adjacent EVL cells, to which the protrusions usually attach (compare with Figure 7). Unfortunately, in over 100 investigated embryos, we failed to
obtain clones with adjacent EpCAM-GFP-positive EVL cells, as would have been necessary to directly test this notion.
doi:10.1371/journal.pgen.1000563.g006
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gastrulation stages (Figure 7A), increased in length during
gastrulation (Figure 7B–7D), and shortened again during segmen-
tation stages (Figure 7F). They were in tight physical contact with
the basal side of neighboring EVL cells, and even formed in most
marginal EVL regions that are devoid of underlying deep cells
(Figure 7B). In agreement with the altered actin pattern (Figure 5J),
these basal protrusions were much broader and shorter in
MZepcam mutants (Figure 7E). TEM sections further revealed
that the closely sealed apical junctional complexes (AJCs) of EVL
cells were basally extended in MZepcam mutants compared to wild-
type controls (Figure 7G–7M). This difference was apparent
throughout all investigated developmental stages from mid
gastrulation through day 5 of development. However, desmosomes
appeared morphologically unaltered (Figure 7G and 7H; and data
not shown).
In addition, consistent with the basal extension of TJs,
immunohistochemistry revealed an increase in the staining
intensity for Tight junction protein 1 (Tjp1/ZO1) [61] in the
lateral membranes of MZepcam mutant EVL cells (Figure 8A and
8B). Supporting results were obtained in EpCAM gain-of-function
studies in madine-darby canine kidney (MDCK) cells, which upon
transfection with GFP-EpCAM displayed reduced membranous
signals for the TJ components Tjp1 and Occludin, whereas
desmoplakin stainings appeared unaltered (Figure S4). However,
opposite alterations were observed for Ecad and its cytoplasmic
binding partners a- and b-catenin (Figure 8C–8H), all of which
displayed reduced membranous staining in MZepcam mutant EVL
cells. In addition, perinuclear Ecad staining in the Golgi apparatus
(Figure 8I) was strongly reduced in mutant cells (Figure 8D)
compared to wild-type controls (Figure 8C). Together, these data
indicate that EpCAM promotes the presence of cadherin-catenin
complexes in the basolateral domain of EVL cells, whereas it
opposes the presence of TJ proteins. In line with these differential
effects, EpCAM was co-localized with Ecad in lateral (Figure 8J) as
well as basal membranes (Figure 8M) of wild-type EVL cells,
Figure 7. Basal protrusions and apical junctions are altered in MZepcam mutants. (A–L) Transmission electron micrographs of EVL–EVL
interphase region of wild-type (A–D,F–K) and MZepcam mutant embryos (E,H–L) at indicated developmental stages. EVL and deep cells are indicated
(evl1/2, dc; A–F), basal protrusions are marked by arrowheads (A–D,F,G), apical junctional complexes (AJCs) and their sizes by brackets (G–K), and
desmosomes by arrows (G–I,K). (A–D) In wild-type embryos, basal protrusions start to form at early gastrula stages (A). Their lengths increase during
gastrulation (B–D), and decrease after gastrulation is completed (F). Lengths in marginal EVL cells (D) are usually higher than in equatorially located
EVL cells (C; see also Figure 6). Protrusions are also formed by marginal EVL cells spanning the cell-free zone between the deep cell layers and the yolk
syncytial layer (YSL; [10]) (B). In mutants, basal protrusions are much shorter and broader (E). (G–L) AJCs are basally extended in the mutants (H,J,L),
compared to wild-type siblings (G,I,K). Panel (M) shows graphical illustration of average lengths of AJCs in wild type and mutant cells at indicated
developmental stages. n=12; standard errors are indicated.
doi:10.1371/journal.pgen.1000563.g007
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(Figure 8K and 8L), consistent with results obtained in cultured
epithelial cells [62]. To investigate whether compromised basal
protrusion formation in MZepcam mutants might be caused by this
gain of TJPs or loss of E-cadherin, we inactivated zebrafish tjp1–3
[14,61] via MO injection, and re-introduced E-cadherin by
injecting different mRNAs or plasmid DNAs encoding mouse E-
cadherin (see Materials and Methods). However, neither of the
treatments led to a significant restoration of ruffle formation
(Figure S5; and data not shown), suggesting that the molecular
effects of EpCAM might be more complex.
EpCAM and Ecad play redundant roles to promote cell–
cell adhesiveness within the EVL of gastrulating embryos
Complementing the failed rescue experiments described above,
we next analyzed whether the defects of MZepcam mutants get
enhanced upon concomitant loss of the (remaining) E-cadherin.
For this purpose, different amounts of ecad MO were injected into
MZepcam mutant embryos. In contrast to epcam, ecad is expressed
both in the EVL and in the deep cells. Strong ecad morphants and
ecad null mutants display defects during epiboly movements of
deep cells (see Introduction), whereas the EVL appeared normal
(Figure 9C and 9G). In striking contrast, and unlike uninjected
Figure 8. In wild-type EVL cells, EpCAM is localized at the basolateral membrane and excluded from the apical domain, while the
molecularcompositionof apico-basalmembranesis altered in MZepcam mutants. (A–H) Immunodetection of Tjp1 (A,B),Ecad (C,D),b-catenin
(E,F) and a-catenin (G,H) in the EVL of wild-type (A,C,E,G) and MZepcam mutant embryos (B,D,F,H) at 90% epiboly stage. Images were acquired and
processed using identical settings for mutant and wild-type samples. Mutants display increased membranous levels of the tight junction protein, but
reduced levels of the cadherin-catenin complex. (I–M) Localization studies in wild-type EVL cells at 90% epiboly stage. (I) Double immunodetection of
Ecad and the Golgi marker GM130-GFP [80], single and merged channels, revealing perinuclear E-cadherin in the Golgi apparatus. (J) Double
immunodetection of Ecad and EpCAM-GFP, single and merged channels, revealing co-localization in a salt-and-pepper-like pattern (compare with [62]).
(K,L) Double immunodetection of Tjp1 and EpCAM-GFP, revealing that EpCAM-GFP is localized basal to Tjp1; (L) shows rotated Z-stack. (M) Triple
immunodetection of EpCAM-GFP, Ecad and RFP (labeling transplanted deep cells lacking EpCAM-GFP); single and merged channels. The white arrow
indicates EpCAM-GFP localized in the basal membrane of the EVL cell (the underlying RFP-positive deep cells lack EpCAM-GFP).
doi:10.1371/journal.pgen.1000563.g008
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with high amounts of ecad MO displayed severely compromised
cell-cell adhesion of EVL cells at early gastrula stages (5.5 hpf;
Figure 9H), leading to embryo lysis at mid gastrulation (Figure 9D).
This effect was strictly layer-autonomous and independent of E-
cadherin in the underlying deep layer, as indicated by the
disrupted morphology of the EVL in genetic mosaics with a
mutant EVL and wild-type deep layers (Figure 9J), but a wild-type
morphology in the opposite combination (Figure 9I). This
indicates that, while dispensable per se, EpCAM and Ecad
together are required for intercellular adhesion within the EVL.
EpCAM and Ecad from the EVL promote epiboly
movements of underlying deep cells
As described above, EpCAM and Ecad are not only co-localized
at the lateral, but also at the basal membranes of EVL cells, facing
the underlying deep cells (Figure 8M). Previous studies have shown
that Ecad is primarily required to mediate the anchorage of deep
cells to the inner surface of the EVL during radial intercalation
processes driving the epiboly of deep cells (see Introduction). To
test whether EpCAM from EVL cells might also be involved in this
anchorage, we carried out genetic interaction studies, injecting
ineffectively low amounts of ecad MO into wild-type or MZepcam
mutant embryos. In mid gastrula wild-type embryos (80% epiboly
stage) injected with such low amounts of ecad MO, epiboly of deep
cells was normal (Figure 10A; n=25/25; compare with Figure 5C).
In contrast, and unlike the very moderate deep cell epiboly defects
of un-injected MZepcam mutants (Figure 5D), mutants injected
with the same low amounts of ecad MO displayed an arrest of deep
cell epiboly at the equator of the embryo (Figure 10B; n=27/29),
similar to the defects of embryos injected with highest amounts of
ecad MO (data not shown; n=20/21) [10]. Time-lapse recording
Figure 9. Combined complete loss of EpCAM and Ecad leads to compromised intercellular adhesion within the EVL of early gastrula
embryos. (A–D) Live animals at the 70% epiboly stage (7 hpf); dorsal to the right; (E–J) phalloidin stainings of the actin cytoskeleton at 50% epiboly
(5.5 hpf). (A,E) wild-type control (WT); (B,F,I) MZepcam mutant control; (C,G) WT injected with high amounts of E-cadherin morpholino
oligonucleotide (ecad MO); (D,H,J) MZepcam mutant injected with high amounts of ecad MO. The regular ecad morphant (C) displays an arrest of
deep cell epiboly at the equator, as previously described [10–12,87], whereas EVL morphology appears normal (G). In contrast, EVL cells of the
ecad;epcam double morphant/mutant embryo lose contact to each other (H; red arrowheads point to sites disassembly sites), and the embryo lyses
(D). (I,J) The same EVL disassembly is observed in genetic mosaics, in which ecad;epcam double morphant/mutant EVL are positioned above
transplanted wild-type deep cells (J; white arrows to disassembly sites), whereas wild-type EVL above ecad;epcam double morphant/mutant deep
cells appear normal (I). Deep cells were transplanted at late blastula stages (3.5 hpf), and immunostained for the tracing marker mCherry in red.
doi:10.1371/journal.pgen.1000563.g009
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the behavior of deep cells. In un-injected embryos or in wild-type
embryos injected with low amounts of ecad MO, radially
intercalating deep cells remained in the exterior layer of the deep
layers, most likely stably attached to the inner surface of the EVL
(Figure 10E and data not shown; n=6/6; 3 videos), whereas in
MZepcam mutants injected with low amounts of ecad MO, cells
usually moved back into more interior layers of the deep layers
(Figure 10F; n=4/5; 3 videos), similar to the situation after
complete knock-down of ecad (Figure 10G; n=5/5; 2 videos).
Figure 10. Concomitant partial loss of Ecad in the EVL of MZepcam mutants leads to severely compromised epiboly movements of
deep cells. (A–D, E,G) wild-type (A,C,E) or MZepam mutant (B,D,G) embryos injected with low amounts of ecad MO; (F) wild-type embryo injected
with high amounts of ecad MO. (A,B) Phalloidin stainings of the actin cytoskeleton at 80% epiboly stage (for explanation of labeling, see Figure 5). The
ecad hypo-morphant appears normal (A; compare with Figure 5C as un-injected control), whereas partial loss of Ecad activity in the epcam mutants
leads to an arrest of deep cell epiboly (B; note the reduced A-dc distance compared to panel A and to Figure 5D). In contrast, EVL epiboly is not more
affected than in the un-injected mutant (B; note the normal A-evl distance compared to Figure 5D). (C,D) Genetic mosaics at 80% epiboly stage, after
co-transplantation of deep cells from wild-type embryos (anti-RFP immunostaining; in red) and from MZepcam mutants injected with low amounts of
ecad MO (anti-GFP immunostaining; in red), shortly before the onset of epiboly (4 hpf). Epiboly behavior of the transplanted deep cells does not
depend on their own genotype, but on that of the host embryo/the overlying EVL. (E–G) Stills of time-lapse video recordings of the external layer of
deep cells, starting at early gastrula stages (5.5 hpf). For evaluation, only cells were considered that moved up from internal into the external layero f
the deep cells during the first half (0–10 min) of the recordings. Individual cells are pseudo-colored in light red when in the external layer, but un-
colored when in lower layers. Note that the cell in (E) remains in the external layer throughout the second half of the video (10–20 min), whereas cells
in (F,G) move up and down. White spots label representative neighboring cells of the external deep cell layer, demonstrating their increasing distance
in (E), but constant distances in (F,G).
doi:10.1371/journal.pgen.1000563.g010
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primarily depend on EpCAM and Ecad function within the
overlying EVL. Thus, in genetic mosaics, deep MZepcam mutant
cells injected with low amounts of ecad MO displayed the same
epiboly behavior like their wild-type neighbors, which was
compromised when the host and the EVL were mutant
(Figure 10C; n=5/5), but normal when the host and the EVL
were wild-type (Figure 10D; n=6/6). Together, this suggests that
EpCAM from the EVL supports the function of Ecad to drive
epiboly of deep cells.
Discussion
EpCAM is a well-established carcinoma marker that in addition
to its diagnostic value for rapidly growing tumors of epithelial
origin is used as a potential target for immunotherapy
[17,29,63,64]. Most of the current studies dedicated to the
function of EpCAM have used in vitro systems, revealing a rather
pleiotropic nature of EpCAM’s roles during tumor progression
and normal epithelial development (reviewed in [18,31]). Initially
proposed to be a cell-cell adhesion molecule [23,33,35], more
recent studies have pointed to additional and, to some extent,
seemingly contrary roles of EpCAM in diverse processes such as
signaling, cell migration, proliferation and differentiation. Some of
these data have led to the notion of a ‘‘double-face’’ of EpCAM
function in promoting both adhesion/tissue integrity and cell
motility/morphogenesis/metastasis [18,31]. Here, using zebrafish
genetics, we present in vivo loss-of-function data largely in line
with this notion, and discuss how the double-face effect might be
achieved on the cellular level.
The zebrafish EpCAM mutants and morphants
Apart from zebrafish, no EpCAM mutants have been described
in any other organism. Two mutant zebrafish alleles were isolated,
both of which are most likely EpCAM nulls (Figure 1 and Figure 2).
Maternal-zygotic (MZ) mutants lacking both maternally and
zygotically supplied epcam gene products display early epiboly
and later skin defects, whereas epiboly seems to be normal in
zygotic mutants and epcam morphants. The weaker phenotype of
zygotic mutants suggests that maternally supplied epcam gene
products, either mRNA or protein, are sufficient to drive epiboly.
The lack of epiboly defects in epcam morphants further points to
maternal EpCAM protein. Translational start site morpholinos as
used here target both maternally and zygotically provided mRNA,
but not maternal protein, suggesting that the weaker phenotype of
epcam morphants compared to MZepcam mutants is due to the
presence of maternally provided EpCAM protein. EpCAM-
specific antibodies will be required to test this notion.
In addition to the epiboly and skin defects that are the focus of
this work, epcam zebrafish mutants display compromised otolith
formation in the developing inner ears (Figure 1 and [45]). The
cellular and molecular basis of this phenotype is unclear, however,
similar otolith defects have been described for zebrafish mutants in
the tight junction component Claudinj [65]. Another site of
prominent zygotic zebrafish epcam expression are the neuromasts
of the lateral line (Figure 2). According to a previous report, loss of
EpCAM function by morpholino injection leads to defects in
neuromast deposition during the posterior-wards migration of the
lateral line primordium [53]. Although nicely in line with the
concept of a role of EpCAM during epithelial morphogenesis, our
analysis of MZepcam mutants could not confirm this phenotypic
trait (Figure S6). Indeed, Villablanca et al. had to inject highest
amounts of morpholinos to obtain the phenotype, suggesting that
it might have been an unspecific effect.
The role of EpCAM in the enveloping cell layer of
gastrulating zebrafish embryos
During gastrulation, epcam is exclusively expressed in cells of the
enveloping layer (EVL; see Introduction). Nevertheless, MZepcam
mutants display moderate defects during epiboly movements of
both the EVL and the underlying deep cell layers (Figure 5). Our
chimeric analyses in combination with E-cadherin inactivation
indicate that the deep cell defects are secondary consequences of
failed EpCAM function in the EVL, whereas the EVL defects
themselves are layer autonomous (see below). During their
spreading over the yolk, EVL cells normally change their shape
and flatten out along the radial axis to increase their horizontal
size. The cellular mechanisms underlying this transition are largely
unknown. Here, we show that they involve basal protrusive
activity of EVL cells, and that this activity is severely compromised
in MZepcam mutants, leading to an overall reduction in the average
horizontal size of mutant EVL cells (Figure 5). Recently, a similar
impairment of EVL epiboly has been described for MZpou5f1
mutants. However, in this case, epiboly defects are accompanied
by increased, rather than reduced protrusive activity of EVL cells
[66]. This indicates that both gain and loss of protrusive activity
can compromise epiboly. Future experiments have to address the
functional connection between pou5fl and epcam.I nM Z epcam
mutants, the lack of basal activity is accompanied by a basal
extension of apical junctional complexes (AJCs) (Figure 7), and by
increased levels of TJ components in apico-basal membranes,
whereas levels of E-cadherin (Ecad) and catenins are reduced
(Figure 8). These effects are consistent with the co-localization of
EpCAM and Ecad in the basolateral membranes of wild-type EVL
cells, and their exclusion from the apical Tjp1 domain (Figure 8).
Together, this suggests that EpCAM pushes the molecular
composition of apico-basal membranes from TJ towards AJ
components. In addition to the membrane, mutants displayed
reduced perinuclear Ecad staining in the Golgi apparatus,
suggesting that EpCAM also affects de novo synthesized Ecad
protein. Currently, we cannot distinguish which of the observed
phenotypic traits are primary, and which secondary. However,
neither knockdown of tjp1–3 nor re-introduction of Ecad led to an
alleviation of the mutant phenotype or a restoration of basal
protrusions, suggesting that EpCAM might have multiple targets
and interaction partners, rather than acting via a single mediator.
Generally, protrusion formation is driven by rearrangements of
the cortical cytoskeleton that are coordinated with local modula-
tions in cellular adhesiveness [67]. Interestingly, according to our
TEM studies, the protrusions of EVL cells primarily attach to the
basal membrane of adjacent other EVL cells, rather than to
underlying deep cells or extracellular matrix components, while
protrusions remain much shorter and broader in MZepcam
mutants (Figure 7). In this light, it is tempting to speculate that
the thinning of EVL cells underlying EVL epiboly might be driven
by the ‘‘crawling’’ of basal protrusions on the basal surface of
adjacent EVL cells, and that EpCAM might be particularly
involved in modulating cell-cell adhesiveness and cortical tension
in basolateral domains of EVL cells (Figure 11A and 11B).
In vivo interaction of EpCAM and E-cadherin to regulate
layer-intrinsic and trans-layer adhesion of the zebrafish
EVL
In contrast to cell culture studies identifying EpCAM as a
functional antagonist of Ecad [20,35], we found that zebrafish
EpCAM and Ecad tightly interact and enhance each other’s effects
to promote EVL integrity as well as deep cell epiboly. While each
of them per se was dispensable for EVL integrity, combined loss of
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PLoS Genetics | www.plosgenetics.org 14 July 2009 | Volume 5 | Issue 7 | e1000563Figure 11. Model of cellular processes at play during EVL epiboly in wild-type embryos and different EpCAM/Ecad-deficient
combinations. Schematic drawings of EVL–EVL–deep cell interphase regions at, from left to right, progressing stages of zebrafish gastrulation. Left
panels represent pre- or early gastrula stages, middle panels mid gastrula stages, and right panels post gastrula stages. (A) wild-type conditions; (B)
MZepcam mutant; (C) MZecpam mutant with concomitant partial loss of E-cadherin; (D) MZepcam mutant with concomitant complete loss of E-
cadherin. At the onset of gastrulation, EVL cells start to from basal protrusions, initiated by cytoskeletal rearrangement to overcome the cortical
surface pressure, as indicated by grey arrow. Protrusions attach to the basal surface of adjacent EVL cell and increase in length. This leads to a
progressive narrowing of the lateral side of the EVL cell, and to an increase of its basal surface, and eventually of its entire horizontal size. Protrusion
growth is dependent on EpCAM function, which might be involved both in the cytoskeletal rearrangement (crossed out grey arrow in B), and/or in
mediating adhesion between the protrusion and the adjacent cell. The latter notion, which would be in line with the existence with homophilic
EpCAM trans bonds, is supported by results obtained via re-introduction of EpCAM into single EVL cells (Figure 6). The gain of basal surface and the
transition from a curved to a straighter shape increases the chance of successful attachment of emerging deep cells (green cell number 2) to the
inner surface of the EVL, thereby linking progression of EVL and deep layer epiboly. However, simultaneous further movement forces are required,
such as directed pulling from the EVL margin, to account for a net gain of basal surface throughout the entire layer (indicated by black arrows).
Otherwise, the surface gain of one cell would be equalized by a corresponding loss of free surface in the adjacent cell. These dynamic EVL cell shape
changes are layer-autonomous and largely independent of the underlying deep cells. Otherwise, it would be impossible to uncouple EVL from deep
layer epiboly, as seen in strong ecad mutants and morphants [10]. In contrast, deep layer epiboly is strictly dependent on a functional EVL. Partial loss
of Ecad in MZepcam mutant EVL cells causes destabilization of the adhesion between the basal side of EVL cells and underlying deep cells (C). As a
consequence, deep cells can move back into more internal layers, and deep layer epiboly is severely compromised. In contrast, EVL epiboly is only
slightly retarded, as in regular MZepcam mutants (due to the persistence of the other moving forces indicated by the black arrow). Adhesion among
EVL cells becomes only severely compromised upon combined complete loss of EpCAM and Ecad (D). This indicates that EVL–deep cell adhesion
requires higher Ecad/EpCAM levels than EVL–EVL cell adhesion (see Text S1 for further details). Our chimera analyses further indicate that for proper
deep cell epiboly, both EpCAM and Ecad are only crucial in the EVL, but dispensable in the deep cells themselves, suggesting that here, other or
additional adhesion molecules (indicated in green) might be involved in mediating trans-adhesion to the overlying EVL. It remains unclear whether
EpCAM and Ecad act in a complex, or as rather independent molecules with partially redundant adhesive properties. Therefore, this model does
distinguish between the two molecules (commonly indicated in red). Not considered is the basal extension of apical junctional complexes in mutants.
doi:10.1371/journal.pgen.1000563.g011
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disassembly during early gastrulation stages (Figure 9). This
indicates that EpCAM and Ecad play essential, yet redundant
roles to mediate proper cell-cell adhesion among EVL cells
(Figure 11D). Similarly, partial inactivation of Ecad, which had no
effect in a wild-type background, led to a complete arrest of deep
cell epiboly in MZepcam mutants (Figure 10A and 10B).
Interestingly, also here, the effect depended purely on EpCAM
and Ecad function in the EVL (Figure 10C and 10D). On the
cellular level, the epiboly arrest was accompanied by a failure of
intercalating deep cells to remain in the external deep layer
directly underneath the EVL (Figure 10E–10G), pointing to
defects in the adhesion between EVL and underlying deep cells,
thus, across different layers (Figure 11C) [12]. In this light, both
the tissue integrity defects caused by loss of EpCAM function in
the background of complete ecad inactivation, and the tissue
morphogenesis defects caused by loss of EpCAM function in the
background of partial ecad inactivation, seem to result from
reduced intercellular adhesion. But what are the reasons for the
exclusive effects on epiboly, but not EVL-EVL adhesion, in the
ecad hypomorphic background? Differential contributions of Ecad
and EpCAM to EVL-EVL versus EVL-deep cell binding could be
one factor. EVL-EVL cell adhesion involves apical junctional
complexes and desmosomes, and might therefore be less
dependent on ‘‘free’’ basolaterally localized EpCAM and Ecad
than EVL-deep cell adhesion, which lacks such junctions.
Alternatively or in addition, the deep cell epiboly arrest might
be due to combined effects on cell adhesiveness and its dynamic
regulation. During gastrulation, deep cells undergo massive spatial
rearrangements in addition to radial intercalations, one of the
driving forces of epiboly. For instance, they simultaneously move
from ventrolateral into dorsal regions of the embryo to form the
embryonic body axis [67]. Therefore, neighborships between EVL
and deep cells need to change rather rapidly. In this light, it is
feasible to speculate that EpCAM might also be involved in
regulating the dynamic dis- and re-assembly of EVL-deep cell
contacts to allow proper morphogenesis. Cadherin contacts can be
regulated at multiple levels [68], and membrane localization of
Ecad has recently been shown to be dynamically regulated via
endocytosis and recycling during gastrulation movements of deep
cells in zebrafish and frog embryos [67,69,70]. Furthermore, the
cytoplasmic domain of EpCAM contains an NPXY internalization
motif [19], which could possibly trigger the concomitant
endocytosis of Ecad, comparable to the recently revealed role of
the transmembrane protein FLRT3 in Xenopus embryos [70].
In sum, we propose that EpCAM and Ecad play rather similar,
and partially redundant roles during zebrafish gastrulation.
Furthermore, they seem to mutually influence each other, with a
positive effect of EpCAM on membranous Ecad levels and,
possibly, Ecad synthesis and recycling. Subject to dynamic
regulation, cadherins are well known for their multiple, and
seemingly contrary effects, not only promoting cell-cell adhesive-
ness and tissue integrity, but also cellular plasticity and cellular
‘‘grip’’ during morphogenesis. Similar mechanisms might underlie
EpCAM’s reported ‘‘double face’’ function also revealed in this
work. Future biochemical studies will be necessary to elucidate the
molecular basis of the EpCAM – E-cadherin partnership. Since
they play largely redundant roles, they do not necessarily have to
physically interact at all. They could for instance mediate different
modes of adhesion, cadherins in connection with the highly
structured actin cytoskeleton and EpCAM more independently of
the cytoskeleton [18,34]. Consistent with this notion, our
immunolocalization studies indicate a salt-and-pepper like distri-
bution of EpCAM and Ecad, rather than complete co-localization
in the basolateral membrane of EVL cells (Figure 8J). However, it
is interesting to note that in the context of nuclear signaling,
complex formation between the intracellular domain of EpCAM
and b-catenin has been observed [41]. Furthermore, more indirect
mechanisms might be at play, involving adapter or signaling
proteins [71].
The later role of EpCAM in the skin
Similar effects of EpCAM might also account for the later defects
in the mutant skin. From mid-segmentation onwards (14 hpf), the
outer EVL, now also called periderm, is juxtaposed against a single
layer of basal keratinocytes, which derive from the ventral
ectoderm, a subpopulation of deep cells initially located in
ventral-animal regions of the pregastrula embryo [5]. Both layers
display epcam expression, and both display compromised epithelial
integrity in epcam mutants. However, the defects in the periderm are
already apparent when the basal layer is still normal (16 hpf;
Figure 3C–3E). This later periderm defects are very similar to those
caused by combined loss of EpCAM and E-cadherin during
gastrulation. It remains unclear, however, why in contrast to the
early stages and despite its maintained expression, E-cadherin fails
to compensate for loss of EpCAM after skin formation. Further-
more, consistent with the aforementioned effect of EpCAM from
the EVL on epiboly movements of the underlying deep cells, our
chimera analyses reveal that defects in the basal layer are due to a
non-autonomous effect from the EVL (Figure 3H and 3I). Also,
similar to the situation during epiboly, epcam mutants display a
persistent basal extension of AJCs in EVL cells during such later
stages (Figure 7J and 7L). Although the role of tight junctions in cell
adhesion is still disputable, it is generally accepted that their impact
compared to adherence junctions and desmosomes is minor
[72,73]. In this light, and in light of the observed negative effect
of the MZepcam mutation on membranous Ecad levels and cell-cell
adhesiveness during gastrulation, we assume that the epithelial
defects of the mutant periderm are due to reduced, rather than
enhanced cell-cell adhesiveness. In addition, defects might be
enhanced by reduced epithelial plasticity. Consistent with this
notion, initial epithelial lesions in the periderm of epcam mutants
were most prominent on the tailbud (Figure 3B) and the head,
regions that undergo massive morphogenesis and that are exposed
to highest mechanical stress. Very similar shedding of skin cells was
previously described for hai1 mutants, which display partial
epithelial-mesenchymal transitions of basal keratinocytes [56].
However, no mesenchymal-like behavior was observed in time-
lapse recordingsof basal keratinocytesor EVL cellsof epcam mutants
(K.S. and M.H., unpublished observations). In sum, these data
suggest that similar to the defects during epiboly, the later skin
defects of epcam mutants are due to compromised intercellular
adhesion and cellular plasticity of epithelial cells.
In light of the reported roles of EpCAM in multiple other
cellular processes, such as cell proliferation and cell differentiation,
we also investigated whether and when skin cells of MZepcam
mutants develop corresponding defects. However, in contrast to
other reported zebrafish skin mutants [74], EVL and basal cells
showed normal levels of terminal differentiation markers (Keratin,
ATPases; Figure S7). Also, although EVL and basal cells displayed
an up to 50% increase in proliferation, this hyper-proliferation
only became apparent several hours after the epithelial defects
(Figure 4B). Furthermore, aggregates of both EVL and basal cells
displayed similar rates of BrdU incorporation like regions remote
of the aggregates (Figure 4C). An interesting side outcome of the
BrdU incorporation studies, also confirmed by time-lapse
recordings (K.S. and M.H., unpublished data), was the demon-
stration that EVL cells divide at all. This had not been shown
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shape changes, and that it later sloughs off, being replaced by cells
deriving from basal cells [5]. However, our data suggest that the
growth of the two larval zebrafish skin layers might involve layer-
autonomous, horizontal cell divisions, rather than or in addition to
vertical growth/replacement, the typical concept of stratified
epithelia.
In conclusion, our studies indicate that loss of EpCAM in the
developing zebrafish skin primarily leads to compromised
epithelial plasticity and adhesiveness, whereas hyper-proliferation
is a secondary consequence, possibly due to the loss of contact
inhibition. Similarly, the higher susceptibility to bacterial infec-
tions and enhanced inflammation of epcam mutants (Figure S2,
Video S1, Video S2) are most likely secondary consequences of
compromised skin integrity.
In contrast to embryonic and larval stages, however, we found
EpCAM to be largely dispensable after metamorphosis, when the
skin has become multi-layered. The reason for this later
dispensability remains unclear. Functional redundancy with other
genes could be one explanation. In mammals, an EpCAM
homologue called Trop2/Tasctd2 exists, which shows approxi-
mately 50% sequence identity to EpCAM, and which has most
likely evolved via a retrotranspositional event [75]. In contrast,
searches of zebrafish databases failed to identify further EpCAM-
related sequences [53] (M.H. and K.S., unpublished data),
suggesting that zebrafish epcam is a single gene. Interestingly, adult
zebrafish epcam mutants even displayed normal cutaneous wound
healing (K. S. and M.H., unpublished data), indicating that despite
its reported elevated expression during epithelial regeneration of
the mammalian liver and kidney [24,28], EpCAM is not required
for epithelial morphogenesis that takes place during zebrafish skin
repair. Future experiments have to reveal whether epcam mutants
are less susceptible to epithelial tumor formation, which would
reinforce its suitability as a target for anti-carcinoma therapies.
Materials and Methods
Fish husbandry
The EpCAM alleles hi2836 and hi2151 were isolated during an
insertional mutagenesis screen [76]. Unless noted otherwise, the
hi2151 allele was used. hi2151 mutants were obtained from
heterozygous (Z+/2) or homozygous parents (MZ2/2). The
Tg(krt4: egfp)gz7 and Tg(bactin:hras-egfp) (allele vu119) transgenic
lines have been described previously [55,77].
Cloning of cDNAs and RNA synthesis and microinjection
The full-length coding region of zebrafish EpCAM cDNA
(GenBank accession number NM_213175) was amplified via RT-
PCR and cloned into pCRII-TOPO (Invitrogen) or upstream of
eGFP into pCS2+ plasmid [78]. To generate pCS2-Ecad-HA, the
full-length coding region of mouse E-cadherin was amplified and
cloned upstream of HA into pCS2+. For antisense probe synthesis,
pCRII-EpCAM was linearized with XbaI and transcribed with
SP6 RNA polymerase. For sense RNA synthesis for microinjec-
tion, pCS2-EpCAM-eGFP, pCS2-Ecad-HA and pCS2-mCherry
(with farnesylation signal; generous gift from Erez Raz) were
linearized with NotI and transcribed using SP6 Message Machine
kit (Ambion); mGFP mRNA [79] and GM130-GFP mRNA were
generated as described [80]. For rescue experiments, EpCAM-
eGFP or Ecad-HA mRNA were injected at 150, 350 (EpCAM) or
100 mg/ml (Ecad), respectively (1.5 nl per embryo), pCS2-
EpCAM-eGFP, pCDNA3.1-Ecad-GFP [81], pCS2-Ecad-HA, or
pL31NU-Ecad-Venus DNA [82] at 350 mg/ml (EpCAM) or
100 mg/ml (Ecad), respectively.
Tissue labeling procedures
In situ hybridizations were performed as previously described
[83], using probes for EpCAM and leukocyte-specific-plastin (lcp1)
[59]. Whole-mount immunostaining was carried out as described
[83], using fluorescently-labeled secondary antibodies or the
Vectastain ABC kit (Axxora) for enzymatic detection. Antibodies,
dilutions used and sources were as follows: anti-p63 (1:200, Santa
Cruz), anti-GFP (1:400, Invitrogen), anti-RFP (1:200; antibodies-
online GmbH, ABIN132020), anti-E-cadherin (1:200, BD Biosci-
ences), anti-ZO-1 (1:200, Zymed), Alexa-Fluor-546 goat anti-
mouse (1:400, Invitrogen) and Alexa-Fluor-488 goat anti-rabbit
(1:400, Invitrogen). Tested anti EpCAM antibodies: A-20 (Santa
Cruz), 1144 (Epitomics), HO-3 [84] and C-215 [85]. For paraffin
sectioning (8 or 16 mm), stained embryos were dehydrated in
ethanol series and clearing in toluene, the specimens were
infiltrated with paraffin, embedded, and sectioned. Epidermal cell
proliferation was assessed by BrdU incorporation followed by
combined anti-p63 and anti-BrdU immunostaining as described
[56]. Apoptotic cells were visualized by TUNEL staining using in-
situ cell death detection kit (Roche). Phalloidin stainings of cortical
actin cytokeleton were carried out with Alexa 488 or Alexa 594
Phalloidin (1:200, Molecular Probes), as described [10].
Morpholino oligonucleotides (MOs) injections and
blebbistatin treatment
epcam MO (59- GTGCAGAGACTTTCCGGCCATATTT-39)
was obtained from Gene Tools (Philomath, OR) and diluted in
Danieau’s buffer [86]. 1.5 nl of a 200 mM MO solution were
injected per embryo at the 1 cell stage. The ecad MO was as
described [87]. For complete knock-down, 1.5 nl of a 200 mM
solution was injected, for synergistic enhancement studies, 1.5 nl
of a 30 mM solution. The tjp1, tjp2 and tjp3 MOs (generous gifts
from Matthias Ko ¨ppen and Carl-Philipp Heisenberg; [14]) were
injected alone or together at 50 to 200 mM each); the msn1 MO
was as described [10] and injected at 200 mM.
Cell transplantations
Clusters of mGFP-labeled basal keratinocytes were obtained by
homotopic transplantation of approximately 50 non-neural ecto-
dermal cells from Tg(bactin:hras-egfp) transgenic donor embryos into
non-transgenic hosts at 6 hpf. Recipients were fixed at 36 hpf,
subjected to anti-GFP and anti-p63 immuno-fluorescence staining,
mounted in 1.5% low melting agarose and analyzed by confocal
microscopy. For localization studies of EpCAM-eGFP on the basal
side of EVL cells (Figure 8), deep cells of mCherry mRNA-injected
cells were transplanted at the sphere stage into EpCAM-eGFP
mRNA-injected hosts. Embryos were fixed at the 90% epiboly stage
for anti-RFP and anti-GFP immunohistochemistry, sectioned, and
analyzed via confocal microscopy. To distinguish whether for
proper EVL adhesion, EpCAM and Ecad are required in the EVL
cells themselves or in underlying deep cells (Figure 9), chimeric
embryos were generated by transplanting deep cells at the sphere
stage from mCherry-labelled wild-type or MZepcam donors into
unlabelled MZepcam hosts injected with high amounts of ecad MO,
or vice versa, followed by fixation at the 90% epiboly stage for anti-
Cherry and phalloidin staining. To investigate whether for deep cell
epiboly, Epcam and Ecad are required in the deep cells or in the
EVL (Figure 10), cells from mCherry mRNA-injected wild-type or
MZepcam mutant donors were transplanted next to cells from mGFP
mRNA + low ecad MO-injected MZepcam mutant donors into
unlabelled MZepcam hosts or MZepcam hosts injected with low ecad
MO. Embryos were fixed at the 90% epiboly stage, and processed
via anti-RFP and anti-GFP immunohistochemistry.
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For time-lapse in vivo imaging, embryos were mounted and
recorded at a Zeiss Axiophot with Nomarski optics and a
Hamamadzu Orca camera, as previously described [79]. 20-
minutes videos were taken at lateral marginal regions, starting at
shield stage (5.5 hpf), with 30 sec intervals. For Figure 10, single
images form the time-lapse video recordings were imported into
Adobe Photoshop, and single cells were pseudo-colored to aid the
presentation [11].
Fluorescent images were taken with a Zeiss Confocal micro-
scope (LSM510 META); Transmission light microscopy was
performed on a Zeiss Axiophot or Leica MZ-8 stereomicroscope.
For transmission electron microscopy, wild-type and mutant fish
were fixed with 2.5% glutaraldehyde in PBS for 30 minutes each
at ambient temperature and then on ice. After washing with PBS,
the larvae were post-fixed with 1% osmium tetroxide in 100 mM
phosphate buffer pH 7.2 for 1 hour on ice, washed with H20,
stained with 1% aqueous uranylacetate for 1 hour, dehydrated in
a graded series of ethanol and finally embedded in Epon. Ultrathin
sections were stained with uranyl acetate and lead citrate and
viewed in Philips CM10 electron microscope.
Supporting Information
Figure S1 epcam mutants form skin cell aggregates. (A) Confocal
image (merged Z-stack) of basal keratinocytes of wild type control
(WT) and maternal/zygotic epcam mutant (MZ2/2) embryos at 2
days post fertilization (dpf), after anti-p63 immunostaining of basal
keratinocytes. Basal cell aggregates of mutant are indicated by red
arrows. (B,C) Overviews (upper panels) and magnified views of tail
region (lower panels) of live WT (left panels) and MZ2/2
mutants (right panels) at 4 days post fertilization (dpf) (B) and 21
dpf, when the skin becomes multi-layered (C). The epidermal
aggregates of mutants persist during further larval development (B;
indicated by red arrows), whereas they are less prominent at 21 dpf
(C). In addition, otoliths have recovered and acquired normal size
at 21 dpf (C; indicated by black arrows). However, the skin of the
mutant has a rougher morphology, the mutant is of reduced size
(C; see different lengths of scale bars=1 mm), and fin develop-
ment is delayed, as judged by the less advanced fin ray formation
in the developing unpaired anal, dorsal and tail fins (C; indicated
by black arrowheads in wild-type animal). Further analyses have to
reveal whether this is a skin/fin-specific defect, or a consequence
of generally delayed development, growth and metamorphosis.
Found at: doi:10.1371/journal.pgen.1000563.s001 (3.16 MB TIF)
Figure S2 MZepcam mutants display increased susceptibility to
cutaneous infections. All panels show lateral views on the tail
region of embryos at 2 dpf, after whole mount in-situ hybridization
for leukocyte-specific-plastin (lcp1) mRNA, a marker for leukocytes
(macrophages and neutrophiles) [59]. (A,B) In wild-type (WT; A)
and maternal-zygotic epcam mutants (MZ2/2; B) kept in semi
sterile medium, leukocytes are found mainly in the blood vessels.
(C,D) Addition of E. coli to the incubation medium stimulates the
presence of innate immune cells in the skin (indicated by blue
arrows in wild-type fish; C). Skin inflammation is much stronger in
the challenged mutant (D) than in the wild-type control (C),
suggesting that the mutant is more susceptible to cutaneous
infections.
Found at: doi:10.1371/journal.pgen.1000563.s002 (1.33 MB TIF)
Figure S3 In contrast to loss of msn1 or treatment with
blebbistatin, loss of epcam does not compromise the constriction
of marginal EVL cells. (A–F) Fluorescent confocal images of
phalloidin stained maternal zygotic-EpCAM mutant (MZ2/2)
and wild type (WT) embryos at 70% epiboly. The leading EVL
cells of both, mutant and WT embryos are constricted by an actin-
myosin string as indicated by the presence of cells with shorter
leading than trailing sides (A,B). This is in contrary to the release
of constriction caused by in wild-type embryos upon treatment
with 15 ug/ml blebbistatin (C) or injection of msn1 MO (D) [10],
suggesting that the EVL epiboly defects of MZepcam and msn1
mutants have a different cellular basis, and that the phenotype of
MZepcam mutants is not caused by reduced actin-myosin
constriction at the EVL-YSL interface. Consistent with this
notion, injection of msn1 MO or blebbistatin treatment in
MZepcam mutants, while releasing marginal constrictions (E,F),
failed to synergistically enhance the EVL epiboly defects, but
rather had pure additive effects (data not shown). Another
possibility would have been that the epiboly defects of MZepcam
mutants are due to increased/precocious, rather than reduced
actin-myosin constriction at the EVL-YSL interface. However,
applying increasingly lower amounts of msn1 MO or blebbistatin
to MZepcam mutants, we never obtained an alleviation of the EVL
epiboly defects (judged by the extrusion of the vegetal-most part of
the yolk at late gastrula stages; compare with Figure 5B), also
making this possibility very unlikely.
Found at: doi:10.1371/journal.pgen.1000563.s003 (1.59 MB TIF)
Figure S4 Overexpression of EpCAM in MDCK cells causes
reduced levels of tight junction proteins. MDCK cells were
transfected with expression vectors driving either GFP (A–C, G–I,
M–O) or zebrafish EpCAM-GFP expression (D–F, J–L, P–R),
plated on cover slips after FACS sorting one day after transfection,
and stained for cell-cell junctional markers 48 hours after plating.
Processed confocal images are shown as merges of entire Z-stacks.
Transfectants were detected by GFP (B, H, N) or EpCAM-GFP
expression (E, K, Q). Protein localization was analyzed with
antibodies against Tjp1/ZO-1 (C, F), Occludin (Occ) (I, L), or
Desmoplakin 1 and 2 (DPI/II) (O, R); panels (A,D,G,J,M,P) show
overlays with GFP fluorescence. DAPI-stained nuclei are shown in
blue (A,D,G,J,M,P); scale bar, 10 mm. Fluorescent labeling of key
components of tight junctions reveals a reduction in membrane
localization of Tjp1 in EpCAM- (F) versus GFP-transfected (C)
cells. Similarly, Occludin staining is reduced in EpCAM
expressing MDCK cells (I, L). However, proteins localizing to
adherens junctions or desmosomes are not altered in expression or
cellular distribution, as shown for DPI/II (O, R). This indicates
that EpCAM expression in MDCK cells leads to a modification in
apical junction complex assembly, resulting in a reduction of key
tight junction proteins at the plasma membrane. (S) Immunoblot
of lysats from FACS-sorted MDCK cells transfected with
EpCAM-GFP (right lane) or, as control, GFP (left lane).
EpCAM-GFP and GFP are expressed at comparable levels (upper
panel). Expression of EpCAM-GFP leads to a significant in Tjp1/
ZO1 protein levels (middle panel; arrow indicate full-length Tjp1/
ZO1 protein). Gapdh was used as loading control (lower panel).
Found at: doi:10.1371/journal.pgen.1000563.s004 (14.76 MB
TIF)
Figure S5 Knockdown of tight junction proteins 1–3 fails to
restore ruffle formation in epcam mutants. Fluorescent confocal
images of phalloidin stained wild type (WT) and maternal-zygotic
EpCAM mutant (MZ2/2) embryos. Single and collective knock
down of tight junction proteins 1–3 via antisense morpholino
oligonucleotides (MO) injections into MZ2/2 embryo (panel 2)
failed to restore the protrusive activity of the mutant EVL cells
back to the WT levels (panel 1, red arrows point to ruffles). If at all,
rescue was very minor (orange arrow in panel 3 points to one of
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MO-injected embryos).
Found at: doi:10.1371/journal.pgen.1000563.s005 (3.63 MB TIF)
Figure S6 Maternal-zygotic epcam mutants have unaltered
numbers of deposited primary neuromasts. (A) 5 dpf old
maternal-zygotic epcam mutants (MZ2/2 ) and wild-type (WT)
controls at 120 hpf, stained with 4-Di-2-ASP for vital labeling of
differentiated hair cells in the larval lateral line. The red
arrowheads point the deposited primary neuromasts. (B) Numbers
of deposited primary neuromasts in WT control and MZ2/2
mutants embryos at 2 dpf. Neuromasts were stained by their
endogenous alkaline phosphatase activity [80]. Contrary to
published data obtained from epcam morpholino studies [53], we
could not detect significant differences in the numbers of deposited
neuromasts between mutant and wild-type fish.
Found at: doi:10.1371/journal.pgen.1000563.s006 (4.10 MB TIF)
Figure S7 Keratinocytes and ionocytes of maternal-zygotic
epcam mutants mutants express markers of terminal differentiation.
To study whether EpCAM is required for terminal differentiation
of epidermal cells, maternal/zygotic epcam mutants (MZ2/2;
B,D) and wild-type controls (WT; A,C) were stained at 1 dpf for
ATPase1b1b and ATPase6v1al transcripts, markers of two ionocytes
subtypes, differentiated osmoregulatory skin cells that stem from
the same pool of epidermal progenitors like keratinocytes (A,B), or
at 3 dpf for keratin protein, a marker for differentiated basal
keratinocytes of zebrafish larvae [74] (C,D). Mutants displayed
normal signal intensities, normal numbers of ionocytes (A,B), and
normal keratin distribution in basal cells (C,D), indicating that
EpCAM is dispensable for the differentiation of epidermal cells. In
addition, keratin distribution in primary neuromasts appeared
normal (indicated by red arrows in C,D).
Found at: doi:10.1371/journal.pgen.1000563.s007 (4.51 MB TIF)
Text S1 Supporting Materials and Methods.
Found at: doi:10.1371/journal.pgen.1000563.s008 (0.03 MB
DOC)
Video S1 Nomarki optics time-lapse movie of 2 days old wild-
type embryo. Tail tip region ventral of notochord and directly
posterior of the connecting flexure between caudal artery and
caudal vein; anterior to the left; dorsal side up. Movies were taken
at a Zeiss Axioplan microscope with a 406water immersion lens;
embryos were anesthetized, embedded in low melting agarose and
imaged using Open Lab software (Improvision). Photos were taken
every 30 sec and movie was generated at a rate of 10 frames/sec.
Found at: doi:10.1371/journal.pgen.1000563.s009 (4.03 MB
MOV)
Video S2 Nomarki optics time-lapse movie of 2 days old
MZepam mutant embryo. The mutant has many more innate
immune cells patrolling throughout the fin tissue. For details, see
legend to Video S1.
Found at: doi:10.1371/journal.pgen.1000563.s010 (3.48 MB
MOV)
Acknowledgments
We are very grateful to Matthias Ko ¨ppen and Carl-Philipp Heisenberg
(tjp1–3 MOs, ecad MO), Walter Hunziker (anti-Tjp3 antibody), Erez Raz
(pCS2-mCherry), and Christine and Bernard Thisse (lcp1) for reagents, and
to Thomas Boehm for the support and cooperation. MPS thanks Rolf
Kemler; KS thanks Gerd Walz for support during the revisions of the work.
Author Contributions
Conceived and designed the experiments: KS MPS MH. Performed the
experiments: KS TJC MPS BK HS. Analyzed the data: KS MPS MH.
Contributed reagents/materials/analysis tools: AA. Wrote the paper: KS
MH.
References
1. Nakamura H, Yasuda M (1979) An electron microscopic study of periderm
cell development in mouse limb buds. Anat Embryol (Berl) 157: 121–
132.
2. M’Boneko V, Merker HJ (1988) Development and morphology of the periderm
of mouse embryos (days 9–12 of gestation). Acta Anat (Basel) 133: 325–336.
3. Cui CY, Kunisada M, Esibizione D, Grivennikov SI, Piao Y, et al. (2007)
Lymphotoxin-beta regulates periderm differentiation during embryonic skin
development. Hum Mol Genet 16: 2583–2590.
4. Vasilyev A, Liu Y, Mudumana S, Mangos S, Lam PY, et al. (2009) Collective
cell migration drives morphogenesis of the kidney nephron. PLoS Biol 7: e9.
doi:10.1371/journal.pbio.1000009.
5. Kimmel CB, Warga RM, Schilling TF (1990) Origin and organization of the
zebrafish fate map. Development 108: 581–594.
6. Le Guellec D, Morvan-Dubois G, Sire JY (2004) Skin development in bony fish
with particular emphasis on collagen deposition in the dermis of the zebrafish
(Danio rerio). Int J Dev Biol 48: 217–231.
7. Warga RM, Kimmel CB (1990) Cell movements during epiboly and gastrulation
in zebrafish. Development 108: 569–580.
8. Kane D, Adams R (2002) Life at the edge: epiboly and involution in the
zebrafish. Results Probl Cell Differ 40: 117–135.
9. Solnica-Krezel L (2006) Gastrulation in zebrafish – all just about adhesion? Curr
Opin Genet Dev 16: 433–441.
10. Ko ¨ppen M, Fernandez BG, Carvalho L, Jacinto A, Heisenberg CP (2006)
Coordinated cell-shape changes control epithelial movement in zebrafish and
Drosophila. Development 133: 2671–2681.
11. Kane DA, McFarland KN, Warga RM (2005) Mutations in half baked/E-
cadherin block cell behaviors that are necessary for teleost epiboly. Development
132: 1105–1116.
12. Shimizu T, Yabe T, Muraoka O, Yonemura S, Aramaki S, et al. (2005) E-
cadherin is required for gastrulation cell movements in zebrafish. Mech Dev 122:
747–763.
13. Sonawane M, Carpio Y, Geisler R, Schwarz H, Maischein HM, et al. (2005)
Zebrafish penner/lethal giant larvae 2 functions in hemidesomosome formation,
maintenance of cellular morphology and growth regulation in the developing
basal epidermis. Development 132: 3255–3265.
14. Kiener TK, Selptsova-Friedrich I, Hunziker W (2008) Tjp3/zo-3 is critical for
epidermal barrier function in zebrafish embryos. Dev Biol 316: 36–49.
15. Herlyn M, Steplewski Z, Herlyn D, Koprowski H (1979) Colorectal carcinoma-
specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad
Sci U S A 76: 1438–1442.
16. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, et al. (1979)
Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell
Genet 5: 957–971.
17. Baeuerle PA, Gires O (2007) EpCAM (CD326) finding its role in cancer.
Br J Cancer 96: 417–423.
18. Trzpis M, McLaughlin PM, de Leij LM, Harmsen MC (2007) Epithelial cell
adhesion molecule: more than a carcinoma marker and adhesion molecule.
Am J Pathol 171: 386–395.
19. Balzar M, Winter MJ, de Boer CJ, Litvinov SV (1999) The biology of the 17-1A
antigen (Ep-CAM). J Mol Med 77: 699–712.
20. Winter MJ, Nagelkerken B, Mertens AE, Rees-Bakker HA, Briaire-de Bruijn IH,
et al. (2003) Expression of Ep-CAM shifts the state of cadherin-mediated
adhesions from strong to weak. Exp Cell Res 285: 50–58.
21. Schiechl H, Dohr G (1987) Immunohistochemical studies of the distribution of a
basolateral-membrane protein in intestinal epithelial cells (GZ1-Ag) in rats using
monoclonal antibodies. Histochemistry 87: 491–498.
22. Klein CE, Cordon-Cardo C, Soehnchen R, Cote RJ, Oettgen HF, et al. (1987)
Changes in cell surface glycoprotein expression during differentiation of human
keratinocytes. J Invest Dermatol 89: 500–506.
23. Cirulli V, Crisa L, Beattie GM, Mally MI, Lopez AD, et al. (1998) KSA antigen
Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphor-
egulatory roles in pancreatic islet development. J Cell Biol 140: 1519–1534.
24. de Boer CJ, van Krieken JH, Janssen-van Rhijn CM, Litvinov SV (1999)
Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic
liver. J Pathol 188: 201–206.
25. Schmelzer E, Reid LM (2008) EpCAM expression in normal, non-pathological
tissues. Front Biosci 13: 3096–3100.
26. Trzpis M, McLaughlin PM, Popa ER, Terpstra P, van Kooten TG, et al. (2008)
EpCAM homologues exhibit epithelial-specific but different expression patterns
in the kidney. Transgenic Res 17: 229–238.
Zebrafish EpCAM Mutant
PLoS Genetics | www.plosgenetics.org 19 July 2009 | Volume 5 | Issue 7 | e100056327. Breuhahn K, Baeuerle PA, Peters M, Prang N, Tox U, et al. (2006) Expression
of epithelial cellular adhesion molecule (Ep-CAM) in chronic (necro-)inflamma-
tory liver diseases and hepatocellular carcinoma. Hepatol Res 34: 50–56.
28. Trzpis M, McLaughlin PM, van Goor H, Brinker MG, van Dam GM, et al.
(2008) Expression of EpCAM is up-regulated during regeneration of renal
epithelia. J Pathol 216: 201–208.
29. Gires O, Klein CA, Baeuerle PA (2009) On the abundance of EpCAM on
cancer stem cells. Nat Rev Cancer 9: 143; author reply 143.
30. Momburg F, Moldenhauer G, Hammerling GJ, Moller P (1987) Immunohis-
tochemical study of the expression of a Mr 34,000 human epithelium-specific
surface glycoprotein in normal and malignant tissues. Cancer Res 47:
2883–2891.
31. Trzpis M, Bremer E, McLaughlin PM, de Leij LF, Harmsen MC (2008)
EpCAM in morphogenesis. Front Biosci 13: 5050–5055.
32. Jojovic M, Adam E, Zangemeister-Wittke U, Schumacher U (1998) Epithelial
glycoprotein-2 expression is subject to regulatory processes in epithelial-
mesenchymal transitions during metastases: an investigation of human cancers
transplanted into severe combined immunodeficient mice. Histochem J 30:
723–729.
33. Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO (1994) Ep-
CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.
J Cell Biol 125: 437–446.
34. Wu ¨rfel J, Rosel M, Seiter S, Claas C, Herlevsen M, et al. (1999) Metastasis-
association of the rat ortholog of the human epithelial glycoprotein antigen
EGP314. Oncogene 18: 2323–2334.
35. Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, et al.
(1997) Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell
interactions mediated by classic cadherins. J Cell Biol 139: 1337–1348.
36. Schmidt DS, Klingbeil P, Schnolzer M, Zoller M (2004) CD44 variant isoforms
associate with tetraspanins and EpCAM. Exp Cell Res 297: 329–347.
37. Ladwein M, Pape UF, Schmidt DS, Schnolzer M, Fiedler S, et al. (2005) The
cell-cell adhesion molecule EpCAM interacts directly with the tight junction
protein claudin-7. Exp Cell Res 309: 345–357.
38. Kominsky SL, Argani P, Korz D, Evron E, Raman V, et al. (2003) Loss of the
tight junction protein claudin-7 correlates with histological grade in both ductal
carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22:
2021–2033.
39. Sauer T, Pedersen MK, Ebeltoft K, Naess O (2005) Reduced expression of
Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading
and metastatic disease. Cytopathology 16: 193–198.
40. Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, et al. (2004) EpCAM is
overexpressed in breast cancer and is a potential target for breast cancer gene
therapy. Cancer Res 64: 5818–5824.
41. Maetzel D, Denzel S, Mack B, Canis M, Went P, et al. (2009) Nuclear signalling
by tumour-associated antigen EpCAM. Nat Cell Biol 11: 162–171.
42. Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, et al. (2004) The carcinoma-
associated antigen EpCAM upregulates c-myc and induces cell proliferation.
Oncogene 23: 5748–5758.
43. Munz M, Zeidler R, Gires O (2005) The tumour-associated antigen EpCAM
upregulates the fatty acid binding protein E-FABP. Cancer Lett 225: 151–157.
44. Simon B, Podolsky DK, Moldenhauer G, Isselbacher KJ, Gattoni-Celli S, et al.
(1990) Epithelial glycoprotein is a member of a family of epithelial cell surface
antigens homologous to nidogen, a matrix adhesion protein. Proc Natl Acad
Sci U S A 87: 2755–2759.
45. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, et al. (2004)
Identification of 315 genes essential for early zebrafish development. Proc Natl
Acad Sci U S A 101: 12792–12797.
46. Mills AA, Zheng B, Wang X-J, Vogel H, Roop DR, Bradley A (1999) p63 is a
p53 homologue required for limb and epidermal morphogenesis. Nature 398:
708–713.
47. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, et al. (1999) p63 is
essential for regenerative proliferation in limb, craniofacial and epithelial
development. Nature 398: 714–718.
48. Bakkers J, Hild M, Kramer C, Furutani-Seiki M, Hammerschmidt M (2002)
Zebrafish DeltaNp63 is a direct target of Bmp signaling and encodes a
transcriptional repressor blocking neural specification in the ventral ectoderm.
Dev Cell 2: 617–627.
49. Lee H, Kimelman D (2002) A dominant-negative form of p63 is required for
epidermal proliferation in zebrafish. Dev Cell 2: 607–616.
50. Yang A, Kaghad M, Caput D, McKeon F (2002) On the shoulders of giants:
p63, p73 and the rise of p53. Trends Genet 18: 90–95.
51. Suh EK, Yang A, Kettenbach A, Bamberger C, Michaelis AH, et al. (2006) p63
protects the female germ line during meiotic arrest. Nature 444: 624–628.
52. Gompel N, Cubedo N, Thisse C, Thisse B, Dambly-Chaudiere C, et al. (2001)
Pattern formation in the lateral line of zebrafish. Mech Dev 105: 69–77.
53. Villablanca EJ, Renucci A, Sapede D, Lec V, Soubiran F, et al. (2006) Control
of cell migration in the zebrafish lateral line: implication of the gene ‘‘tumour-
associated calcium signal transducer,’’ tacstd. Dev Dyn 235: 1578–1588.
54. Thisse B, Pflumio S, Fu ¨rthauer M, Loppin B, Heyer V, Degrave A, Woehl R,
Lux A, Steffan T, Charbonnier XQ, Thisse C (2001) Expression of the zebrafish
genome during embryogenesis (NIH R01 RR15402). ZFIN Direct Data
Submission.
55. Gong Z, Ju B, Wang X, He J, Wan H, et al. (2002) Green fluorescent protein
expression in germ-line transmitted transgenic zebrafish under a stratified
epithelial promoter from keratin8. Dev Dyn 223: 204–215.
56. Carney TJ, von der Hardt S, Sonntag C, Amsterdam A, Topczewski J, et al.
(2007) Inactivation of serine protease Matriptase1a by its inhibitor Hai1 is
required for epithelial integrity of the zebrafish epidermis. Development 134:
3461–3471.
57. Mathias JR, Dodd ME, Walters KB, Rhodes J, Kanki JP, et al. (2007) Live
imaging of chronic inflammation caused by mutation of zebrafish Hai1. J Cell
Sci 120: 3372–3383.
58. Rhodes J, Hagen A, Hsu K, Deng M, Liu TX, et al. (2005) Interplay of pu.1 and
gata1 determines myelo-erythroid progenitor cell fate in zebrafish. Dev Cell 8:
97–108.
59. Herbomel P, Thisse B, Thisse C (1999) Ontogeny and behaviour of early
macrophages in the zebrafish embryo. Development 126: 3735–3745.
60. Meijer AH, van der Sar AM, Cunha C, Lamers GE, Laplante MA, et al. (2008)
Identification and real-time imaging of a myc-expressing neutrophil population
involved in inflammation and mycobacterial granuloma formation in zebrafish.
Dev Comp Immunol 32: 36–49.
61. Kiener TK, Sleptsova-Friedrich I, Hunziker W (2007) Identification, tissue
distribution and developmental expression of tjp1/zo-1, tjp2/zo-2 and tjp3/zo-3
in the zebrafish, Danio rerio. Gene Expr Patterns 7: 767–776.
62. Balzar M, Prins FA, Bakker HA, Fleuren GJ, Warnaar SO, et al. (1999) The
structural analysis of adhesions mediated by Ep-CAM. Exp Cell Res 246:
108–121.
63. Riethmu ¨ller G, Holz E, Schlimok G, Schmiegel W, Raab R, et al. (1998)
Monoclonal antibody therapy for resected Dukes’ C colorectal cancer: seven-
year outcome of a multicenter randomized trial. J Clin Oncol 16: 1788–1794.
64. Winter MJ, Nagtegaal ID, van Krieken JH, Litvinov SV (2003) The epithelial
cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in
surgical pathology. Am J Pathol 163: 2139–2148.
65. Hardison AL, Lichten L, Banerjee-Basu S, Becker TS, Burgess SM (2005) The
zebrafish gene claudinj is essential for normal ear function and important for the
formation of the otoliths. Mech Dev 122: 949–958.
66. Lachnit M, Kur E, Driever W (2008) Alterations of the cytoskeleton in all three
embryonic lineages contribute to the epiboly defect of Pou5f1/Oct4 deficient
MZspg zebrafish embryos. Dev Biol 315: 1–17.
67. Hammerschmidt M, Wedlich D (2008) Regulated adhesion as a driving force of
gastrulation movements. Development 135: 3625–3641.
68. Yap AS, Crampton MS, Hardin J (2007) Making and breaking contacts: the
cellular biology of cadherin regulation. Curr Opin Cell Biol 19: 508–514.
69. Ulrich F, Krieg M, Schotz EM, Link V, Castanon I, et al. (2005) Wnt11
functions in gastrulation by controlling cell cohesion through Rab5c and E-
cadherin. Dev Cell 9: 555–564.
70. Ogata S, Morokuma J, Hayata T, Kolle G, Niehrs C, et al. (2007) TGF-beta
signaling-mediated morphogenesis: modulation of cell adhesion via cadherin
endocytosis. Genes Dev 21: 1817–1831.
71. Winter MJ, Cirulli V, Briaire-de Bruijn IH, Litvinov SV (2007) Cadherins are
regulated by Ep-CAM via phosphaditylinositol-3 kinase. Mol Cell Biochem 302:
19–26.
72. Kubota K, Furuse M, Sasaki H, Sonoda N, Fujita K, et al. (1999) Ca(2+)-
independent cell-adhesion activity of claudins, a family of integral membrane
proteins localized at tight junctions. Curr Biol 9: 1035–1038.
73. Turksen K, Troy TC (2004) Barriers built on claudins. J Cell Sci 117:
2435–2447.
74. Webb AE, Driever W, Kimelman D (2008) psoriasis regulates epidermal
development in zebrafish. Dev Dyn 237: 1153–1164.
75. Linnenbach AJ, Seng BA, Wu S, Robbins S, Scollon M, et al. (1993)
Retroposition in a family of carcinoma-associated antigen genes. Mol Cell Biol
13: 1507–1515.
76. Amsterdam A, Burgess S, Golling G, Chen W, Sun Z, et al. (1999) A large-scale
insertional mutagenesis screen in zebrafish. Genes Dev 13: 2713–2724.
77. Cooper MS, Szeto DP, Sommers-Herivel G, Topczewski J, Solnica-Krezel L, et
al. (2005) Visualizing morphogenesis in transgenic zebrafish using BODIYP TR
methyl ester dye as a vital counterstain for GFP. Dev Dyn 232: 359–368.
78. Huang H, Marsh-Armstrong N, Brown DD (1999) Metamorphosis is inhibited
in transgenic Xenopus laevis tadpoles that overexpress type III deiodinase. Proc
Natl Acad Sci U S A 96: 962–967.
79. von der Hardt S, Bakkers J, Inbal A, Carvalho L, Solnica-Krezel L, et al. (2007)
The Bmp gradient of the zebrafish gastrula guides migrating lateral cells by
regulating cell-cell adhesion. Curr Biol 17: 475–487.
80. Pouthas F, Girard P, Lecaudey V, Ly TB, Gilmour D, et al. (2008) In migrating
cells, the Golgi complex and the position of the centrosome depend on
geometrical constraints of the substratum. J Cell Sci 121: 2406–2414.
81. Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ (2005) Deconstructing the
cadherin-catenin-actin complex. Cell 123: 889–901.
82. Huber O, Kemler R, Langosch D (1999) Mutations affecting transmembrane
segment interactions impair adhesiveness of E-cadherin. J Cell Sci 112( Pt 23):
4415–4423.
83. Hammerschmidt M, Pelegri F, Mullins MC, Kane DA, van Eeden FJ, et al.
(1996) dino and mercedes, two genes regulating dorsal development in the
zebrafish embryo. Development 123: 95–102.
Zebrafish EpCAM Mutant
PLoS Genetics | www.plosgenetics.org 20 July 2009 | Volume 5 | Issue 7 | e100056384. Ruf P, Gires O, Jager M, Fellinger K, Atz J, et al. (2007) Characterisation of the
new EpCAM-specific antibody HO-3: implications for trifunctional antibody
immunotherapy of cancer. Br J Cancer 97: 315–321.
85. Bjork P, Jonsson U, Svedberg H, Larsson K, Lind P, et al. (1993) Isolation,
partial characterization, and molecular cloning of a human colon adenocarci-
noma cell-surface glycoprotein recognized by the C215 mouse monoclonal
antibody. J Biol Chem 268: 24232–24241.
86. Nasevicius A, Ekker SC (2000) Effective targeted gene ‘knockdown’ in zebrafish.
Nat Genet 26: 216–220.
87. Montero JA, Carvalho L, Wilsch-Brauninger M, Kilian B, Mustafa C, et al.
(2005) Shield formation at the onset of zebrafish gastrulation. Development 132:
1187–1198.
88. Kane DA, Kimmel CB (1993) The zebrafish midblastula transition. Develop-
ment 119: 447–456.
Zebrafish EpCAM Mutant
PLoS Genetics | www.plosgenetics.org 21 July 2009 | Volume 5 | Issue 7 | e1000563